217 related articles for article (PubMed ID: 16950806)
1. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.
Cantero G; Campanella C; Mateos S; Cortés F
Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II.
Cantero G; Pastor N; Mateos S; Campanella C; Cortés F
Mutat Res; 2006 Jul; 599(1-2):160-6. PubMed ID: 16574165
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
Snyder RD; Gillies PJ
Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
[TBL] [Abstract][Full Text] [Related]
4. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
[TBL] [Abstract][Full Text] [Related]
5. Cells lacking DNA topoisomerase II beta are resistant to genistein.
López-Lazaro M; Willmore E; Austin CA
J Nat Prod; 2007 May; 70(5):763-7. PubMed ID: 17411092
[TBL] [Abstract][Full Text] [Related]
6. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation.
Pastor N; Cantero G; Campanella C; Cortés F
Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205
[TBL] [Abstract][Full Text] [Related]
7. Toward a comprehensive model for induced endoreduplication.
Cortés F; Mateos S; Pastor N; Domínguez I
Life Sci; 2004 Nov; 76(2):121-35. PubMed ID: 15519359
[TBL] [Abstract][Full Text] [Related]
8. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells.
Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F
Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795
[TBL] [Abstract][Full Text] [Related]
9. The mycotoxin ochratoxin A inhibits DNA topoisomerase II and induces polyploidy in cultured CHO cells.
Cosimi S; Orta L; Mateos S; Cortés F
Toxicol In Vitro; 2009 Sep; 23(6):1110-5. PubMed ID: 19490938
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
Hasinoff BB; Wu X; Begleiter A; Guziec LJ; Guziec F; Giorgianni A; Yang S; Jiang Y; Yalowich JC
Cancer Chemother Pharmacol; 2006 Jan; 57(2):221-33. PubMed ID: 16010589
[TBL] [Abstract][Full Text] [Related]
11. The free radical scavenging activity of four flavonoids determined by the comet assay.
Horvathova K; Novotny L; Vachalkova A
Neoplasma; 2003; 50(4):291-5. PubMed ID: 12937843
[TBL] [Abstract][Full Text] [Related]
12. Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity.
Lanoue L; Green KK; Kwik-Uribe C; Keen CL
Exp Biol Med (Maywood); 2010 Jan; 235(1):77-89. PubMed ID: 20404022
[TBL] [Abstract][Full Text] [Related]
13. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
López-Lázaro M; Willmore E; Austin CA
Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993
[TBL] [Abstract][Full Text] [Related]
14. Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells.
Neukam K; Pastor N; Cortés F
Mutat Res; 2008 Jun; 654(1):8-12. PubMed ID: 18541453
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin.
Olaharski AJ; Mondrala ST; Eastmond DA
Mutat Res; 2005 Apr; 582(1-2):79-86. PubMed ID: 15781213
[TBL] [Abstract][Full Text] [Related]
16. Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs.
Meikle I; Cummings J; Macpherson JS; Smyth JF
Anticancer Drug Des; 1995 Oct; 10(7):515-27. PubMed ID: 7495476
[TBL] [Abstract][Full Text] [Related]
17. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method.
Romanová D; Vachálková A; Cipák L; Ovesná Z; Rauko P
Neoplasma; 2001; 48(2):104-7. PubMed ID: 11478688
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Bridewell DJ; Finlay GJ; Baguley BC
Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884
[TBL] [Abstract][Full Text] [Related]
19. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
Constantinou AI; Husband A
Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967
[TBL] [Abstract][Full Text] [Related]
20. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor.
Hajji N; Mateos S; Pastor N; Domínguez I; Cortés F
Mutat Res; 2005 May; 583(1):26-35. PubMed ID: 15866463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
